Neurofibromatosis is a group of rare genetic disorders that cause benign tumors to form on nerve tissue. Tumors in this disorder are usually noncancerous (benign), but can sometimes become cancerous ...
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. In a recent update, AstraZeneca announced a new clinical study titled ...
No, your eyes aren't playing tricks on you. There really were a few dozen scantily-clad runners making their way down Division Street on Saturday afternoon. The group was baring almost all for a good ...
Neurofibromatosis type 1 (NF1) is a genetic condition that affects the skin, nervous system, and other parts of the body. The condition, formerly called Von Recklinghausen disease, causes changes in ...
Neurofibromatosis type 1 (NF1) is a genetic condition that causes tumors to grow along nerves in the skin, brain, and other parts of the body. These tumors are usually noncancerous (benign), but they ...
INDIANAPOLIS — A new study led by Indiana University School of Medicine researchers revealed a potential strategy to address neurobehavioral challenges associated with neurofibromatosis type 1, or NF1 ...
Caleb McLaughlin, 8, of the Center Grove area holds a sign marking the route for Walk4NF, a fundraiser and community event for NF Midwest, on May 17 at White River State Park. Caleb has ...
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on nerves throughout the body. The federal agency said on Tuesday it ...
On the outside, Yoseph Williamson looks like a typical 14-year-old. He’s a personable kid with an easy smile and a curious mind. But lying beneath his skin are a number of painful tumors from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback